LGALS7 and gastric cancer: Kim et al. indicated that, given the fact that the expression of galectin-7 in gastric cancer is regulated by DNA hypermethylation (as discussed previously in Section 2), the DNA methylation of galectin-7 is a promising candidate biomarker for application in gastric cancer [54].